We are live on ! Find out more
PALI icon

Palisade Bio

5 hedge funds and large institutions have $1.21M invested in Palisade Bio in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% more ownership

Funds ownership: 0%0% (0%)

4% less capital invested

Capital invested by funds: $1.26M → $1.21M (-$45.1K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$558K
ACM
2
Alethea Capital Management
Washington
$176K
William Blair & Company
3
William Blair & Company
Illinois
$93K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$88K
BlackRock
5
BlackRock
New York
$75K
PAM
6
Panagora Asset Management
Massachusetts
$32K
Northern Trust
7
Northern Trust
Illinois
$28K
VF
8
Virtu Financial
New York
$26K
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$23K
BRWA
10
B. Riley Wealth Advisors
Florida
$20K
Citadel Advisors
11
Citadel Advisors
Florida
$15K
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$15K
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$13K
UBS Group
14
UBS Group
Switzerland
$12K
BF
15
BOK Financial
Oklahoma
$11K
Wells Fargo
16
Wells Fargo
California
$7K
CG
17
Cutler Group
California
$5K
ML
18
McAdam LLC
Pennsylvania
$4K
CA
19
Centerpoint Advisors
Massachusetts
$3K
Group One Trading
20
Group One Trading
Illinois
$3K
OIA
21
OneDigital Investment Advisors
Kansas
$3K
RCAG
22
Rehmann Capital Advisory Group
Michigan
$1.4K
Bank of America
23
Bank of America
North Carolina
$1K
MSA
24
Marino Stram & Associates
Massachusetts
$1K
Morgan Stanley
25
Morgan Stanley
New York
$1K

PALI Hedge Fund Activity: Q3 2018 in Review

5 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2018, worth a combined $1.21M — down 3.6% from $1.26M a quarter earlier.

Fund positioning in PALI was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held Palisade Bio (PALI) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $1.21M of Palisade Bio stock for Q3 2018, down 3.6% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q3 2018 and 0 closed out.

Based on aggregated 13F filings for Q3 2018.